At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 24 enrolled
Drug / intervention
Digoxin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Dulaglutide (LY2189265) on the Pharmacokinetics of Digoxin in Healthy Subjects
In Brief
A Phase 1 clinical trial evaluating Digoxin and Dulaglutide for Diabetes Mellitus, Type 2. Completed, enrolled 24 participants across 1 site.
Detailed Summary
The purpose of this study is to study how the body processes digoxin and the effect of dulaglutide on how digoxin is processed by the body. Information about any side effects that may occur will also be collected. This study is for research purposes only and is not intended to treat any medical condition. This research study requires that a blood sample be obtained and stored for future research involving genetic analysis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2011
First PostedSep 2011
Primary CompletionNov 2011
TodayJul 2026
First PostedSep 19, 2011
Enrollment StartSep 1, 2011
Primary CompletionNov 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 14.8 years ago
Interventions
Digoxindrug
Administered orally
Dulaglutidebiological
Administered as subcutaneous injection